1-68444632-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BS3_SupportingBA1

This summary comes from the ClinGen Evidence Repository: NM_000329.3(RPE65):c.394G>A is a missense variant that replaces alanine with threonine at codon 132. This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.01113, with 372 alleles / 30614 total alleles in the South Asian population (with 6 homozygotes), which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.008 (BA1). The computational predictor REVEL gives a score of 0.548, which is above the ClinGen LCA / eoRD VCEP threshold of <0.3 and does not strongly predict a non-damaging effect on RPE65 function. The splicing impact predictor SpliceAI gives a score of 0.03 for splice acceptor loss, which is below the ClinGen LCA / eoRD VCEP recommended threshold of ≥0.2 and does not strongly predict an impact on splicing. The variant exhibited 50% enzymatic activity in an isomerohydrolase assay relative to the wild-type control, which is higher than the ClinGen LCA / eoRD BS3_Supporting threshold of >50% activity, indicating that it largely preserves] normal protein function (PMID:16150724, BS3_Supporting). In summary, this variant meets the criteria to be classified as benign for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BS3_Supporting. (VCEP specifications version 1.0.0; date of approval 09/21/2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA226547/MONDO:0100368/120

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 26 hom. )

Consequence

RPE65
NM_000329.3 missense

Scores

1
7
10

Clinical Significance

Benign reviewed by expert panel U:2B:9O:1

Conservation

PhyloP100: 5.74
Variant links:
Genes affected
RPE65 (HGNC:10294): (retinoid isomerohydrolase RPE65) The protein encoded by this gene is a component of the vitamin A visual cycle of the retina which supplies the 11-cis retinal chromophore of the photoreceptors opsin visual pigments. It is a member of the carotenoid cleavage oxygenase superfamily. All members of this superfamily are non-heme iron oxygenases with a seven-bladed propeller fold and oxidatively cleave carotenoid carbon:carbon double bonds. However, the protein encoded by this gene has acquired a divergent function that involves the concerted O-alkyl ester cleavage of its all-trans retinyl ester substrate and all-trans to 11-cis double bond isomerization of the retinyl moiety. As such, it performs the essential enzymatic isomerization step in the synthesis of 11-cis retinal. Mutations in this gene are associated with early-onset severe blinding disorders such as Leber congenital. [provided by RefSeq, Oct 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BS3
BA1

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RPE65NM_000329.3 linkuse as main transcriptc.394G>A p.Ala132Thr missense_variant 5/14 ENST00000262340.6
LOC124904198XR_007066164.1 linkuse as main transcriptn.72-3900C>T intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RPE65ENST00000262340.6 linkuse as main transcriptc.394G>A p.Ala132Thr missense_variant 5/141 NM_000329.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00147
AC:
224
AN:
152118
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.0193
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.00101
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00294
AC:
739
AN:
251320
Hom.:
9
AF XY:
0.00352
AC XY:
478
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.0211
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0122
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000836
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00168
AC:
2456
AN:
1461858
Hom.:
26
Cov.:
32
AF XY:
0.00200
AC XY:
1451
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.000872
Gnomad4 ASJ exome
AF:
0.0208
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0116
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000595
Gnomad4 OTH exome
AF:
0.00306
GnomAD4 genome
AF:
0.00145
AC:
221
AN:
152236
Hom.:
0
Cov.:
32
AF XY:
0.00150
AC XY:
112
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0000963
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.0193
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0135
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.00101
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00171
Hom.:
1
Bravo
AF:
0.00112
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00287
AC:
348
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.00124

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:9Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Leber congenital amaurosis 2 Benign:3
Likely benign, criteria provided, single submitterresearchBroad Center for Mendelian Genomics, Broad Institute of MIT and Harvard-The p.Ala132Thr variant in RPE65 has been identified in 2 homozygous siblings from 1 family with retinitis pigmentosa (PMID: 9501220), and in the heterozygous state in 2 unrelated individuals with retinitis pigmentosa from India and Dubai respectively (PMID: 24066033, 24265693). In vitro functional studies provide some evidence that the p.Ala132Thr variant may slightly impact protein function (PMID: 16150724). However, these types of assays may not accurately represent biological function and this variant has been identified in >1% of South Asian chromosomes and 4 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for autosomal recessive retinitis pigmentosa. -
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabJun 10, 2021- -
not provided Benign:2Other:1
not provided, no classification providedliterature onlyRetina International-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024RPE65: BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 05, 2018This variant is associated with the following publications: (PMID: 18722466, 21931134, 11095629, 16150724, 24066033, 9501220, 27535533, 26355662, 26626312) -
Leber congenital amaurosis 2;C3151086:Retinitis pigmentosa 20 Benign:2
Likely benign, criteria provided, single submitterclinical testingCounsylMar 06, 2017- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Leber congenital amaurosis Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Apr 03, 2020- -
Retinitis pigmentosa 20 Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyOMIMMar 17, 1998- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 03, 2022- -
RPE65-related recessive retinopathy Benign:1
Benign, reviewed by expert panelcurationClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGenDec 22, 2023NM_000329.3(RPE65):c.394G>A is a missense variant that replaces alanine with threonine at codon 132. This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.01113, with 372 alleles / 30614 total alleles in the South Asian population (with 6 homozygotes), which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.008 (BA1). The computational predictor REVEL gives a score of 0.548, which is above the ClinGen LCA / eoRD VCEP threshold of <0.3 and does not strongly predict a non-damaging effect on RPE65 function. The splicing impact predictor SpliceAI gives a score of 0.03 for splice acceptor loss, which is below the ClinGen LCA / eoRD VCEP recommended threshold of greater than or equal to 0.2 and does not strongly predict an impact on splicing. The variant exhibited 50% enzymatic activity in an isomerohydrolase assay relative to the wild-type control, which is higher than the ClinGen LCA / eoRD BS3_Supporting threshold of >50% activity, indicating that it largely preserves] normal protein function (PMID: 16150724, BS3_Supporting). In summary, this variant meets the criteria to be classified as benign for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BS3_Supporting. (VCEP specifications version 1.0.0; date of approval 09/21/2023). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.057
T
BayesDel_noAF
Pathogenic
0.32
CADD
Uncertain
23
DANN
Benign
0.97
DEOGEN2
Uncertain
0.76
D
Eigen
Benign
0.0099
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.014
T
MetaSVM
Uncertain
0.16
D
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
1.0
A
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-0.76
N
REVEL
Uncertain
0.55
Sift
Benign
0.50
T
Sift4G
Benign
0.47
T
Polyphen
0.012
B
Vest4
0.78
MVP
0.96
MPC
0.054
ClinPred
0.019
T
GERP RS
5.0
Varity_R
0.23
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61752878; hg19: chr1-68910315; API